Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Piergiorgio Pettazzoni

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9039-2463; OpenAlex author ID A5076485100. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. Author Correction: Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. First author DOI 10.1038/s41586-026-10488-6↗
  2. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Co-author DOI 10.1038/s41586-019-1062-1↗
  3. Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. Co-author DOI 10.1038/nature21064↗
  4. In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. Co-author DOI 10.1016/j.celrep.2016.05.063↗
  5. Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-14-1854↗
  6. Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Co-author DOI 10.1016/j.cell.2014.06.003↗
  7. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. First author DOI 10.1038/nature13611↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrea Viale · 7 shared papers, 2014–2026 · strength 0.43
  2. Huamin Wang · 7 shared papers, 2014–2026 · strength 0.43
  3. Timothy Paul Heffernan · 7 shared papers, 2014–2026 · strength 0.43
  4. Ronald Anthony Depinho · 7 shared papers, 2014–2026 · strength 0.43
  5. Giulio Francesco Draetta · 7 shared papers, 2014–2026 · strength 0.43
  6. Alessandro Carugo · 6 shared papers, 2014–2026 · strength 0.41
  7. Jason B. Fleming · 6 shared papers, 2014–2026 · strength 0.41
  8. Haoqiang Ying · 6 shared papers, 2014–2026 · strength 0.40
  9. Wantong Yao · 6 shared papers, 2014–2026 · strength 0.39
  10. Avnish Kapoor · 5 shared papers, 2014–2026 · strength 0.35
  11. Giannicola Genovese · 5 shared papers, 2014–2026 · strength 0.34
  12. Virginia Giuliani · 4 shared papers, 2014–2026 · strength 0.31
  13. Ya’an Kang · 3 shared papers, 2014–2026 · strength 0.27
  14. Lewis C. Cantley · 2 shared papers, 2014–2026 · strength 0.23
  15. Emanuela Brunetto · 2 shared papers, 2014–2026 · strength 0.23
  16. Alec C. Kimmelman · 2 shared papers, 2014–2026 · strength 0.23
  17. Costas Andreas Lyssiotis · 2 shared papers, 2014–2026 · strength 0.23
  18. Anirban Maitra · 3 shared papers, 2016–2019 · strength 0.14
  19. Lynda Chin · 3 shared papers, 2014–2017 · strength 0.11
  20. Johnathon Lynn Rose · 2 shared papers, 2016–2019 · strength 0.10
  21. Jianhua Zhang · 2 shared papers, 2014–2017 · strength 0.07
  22. Yan Liang · 1 shared paper, 2019 · strength 0.06
  23. I-Lin Ho · 1 shared paper, 2019 · strength 0.06
  24. Jun Yao · 1 shared paper, 2019 · strength 0.06
  25. Ziheng Chen · 1 shared paper, 2019 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.